Large companies demonstrated stronger net profit growth for the March 2026 quarter, with net profit growing by 30% for large-caps and 16% for small-caps, while mid-caps saw a 4% decline according to ET Intelligence Group's market cap-based analysis of corporate India's performance. However, the profitability story reveals a critical distinction - while large-caps achieved higher absolute growth, their performance was significantly boosted by one-off gains, with operating margin contraction of 210 basis points year-on-year compared to 40 basis points and 125 basis points for mid and small-cap groups respectively. The large-cap group maintained higher operating margins at 19.4% versus the sample's 17.9%, but this came at the cost of greater volatility in their profitability metrics.
Despite strong profit growth, large-caps faced challenges in top-line expansion, with aggregate revenue growth of 10% lagging significantly behind mid-caps at 12.4% and small-caps at 13.4%. This performance disparity reflects the underlying strength of mid and small-cap companies in driving revenue momentum, even as large-caps benefited from one-off gains. The resilient financial performance of these smaller companies is evident in their margin profiles, with mid-caps operating at 15.2% margins and small-caps at 11.2%, demonstrating more sustainable business models compared to the large-cap sector's reliance on exceptional items for profit enhancement.
The divergent performance between large and smaller companies is clearly reflected in stock market indices, with BSE 150 MidCap and BSE 250 SmallCap indices gaining 14% and 22% respectively over the past three months, significantly outpacing the BSE Sensex and BSE 100 indices which posted 3% and 6% returns respectively. This market performance validates the fundamental strength of mid and small-cap companies in generating sustainable revenue growth and maintaining healthier margins. As Invexa Capital's Tushar Bohra noted, the divergence between benchmark indices and broader market action has become increasingly pronounced, with significant activity occurring beneath the surface of major indices.
Among sectors, Bohra identified financial services as one of the most compelling opportunities currently available, with almost all major investors and fund managers positive on banks and NBFCs. The pharmaceutical sector remains a preferred investment theme, with at least five pharma holdings hitting new lifetime highs in the last one month. Bohra highlighted export-orientated sectors and import-substitution opportunities as key structural themes, noting that a weaker rupee has improved India's competitiveness relative to trading partners. The manufacturing sector may emerge as a major beneficiary, with significant scope for manufacturing-led companies to deliver better earnings and returns in the current market environment.
This domestic performance occurs against the backdrop of a global trend toward large-cap dominance, with large-caps outperforming mid- and small-cap counterparts across most global regions over the past decade, according to Trustnet's analysis. However, India's mid and small-cap sectors are demonstrating resilience and outperforming their global counterparts, with mid-cap and small-cap stocks witnessing a sharp rally despite the global trend. The combination of strong domestic performance and favorable structural themes positions India's mid and small-cap segments well for continued outperformance in the coming quarters.
